Med-ERRS provides consultative services, either on a per-project basis or on retainer, for any issues that pertain to the safe use of a product, including, but not limited to:

• Trademarks
• Packaging
• Instructions for use
• Medication guides
• Nonproprietary names

Since other aspects of product marketing are also under the scrutiny of regulatory bodies, our consulting can include the review of advertising or promotional materials to ensure that messages are communicated in a manner that does not lead to confusion or error. When necessary, we use outside collaborators, such as market researchers and human factors engineers, to provide a wider range of expertise.

Med-ERRS can also review and analyze any post-marketing error reports to determine what risk-mitigation strategies need to be taken. Other issues related to post-marketing error reports are handled by our parent company, ISMP, which now has PSO (patient safety organization) status.

• Focused FMEA
• Advisory groups
• Technology consults